Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Lee Wallace, MD, joined the Department of Cardiothoracic Anesthesia at Cleveland Clinic in 1994. He is Assistant Director of the Cardiothoracic Anesthesia Fellowship and Co-Director of Intraoperative Echocardiography Training for anesthesiology residents and cardiothoracic anesthesia fellows.
Dr. Wallace received an engineering degree from Auburn University, in Auburn, Ala., and a medical degree from the University of Alabama School of Medicine, in Birmingham, Ala. He completed both a residency in anesthesiology and a fellowship in cardiac anesthesiology at The Johns Hopkins University School of Medicine, in Baltimore, Md. He also completed a fellowship in echocardiography at Cleveland Clinic. He is certified by both the American Board of Anesthesiology and the National Board of Echocardiography.
He has participated as faculty at many national conferences on anesthesiology and perioperative echocardiography. He teaches at the Cleveland Clinic Lerner College of Medicine and serves as the Medical Advisor for the Cleveland Clinic Foundation School of Perfusion.
His specialty interests include performing and teaching intraoperative echocardiography, anesthesia for heart and lung transplantation, anesthesia for lung and aortic surgery, anesthesia for robotic and other minimally invasive surgery and anesthesia for percutaneous valve repair/replacement.
cardiothoracic anesthesia, cardiothoracic anesthesiology, fellow and resident education, intraoperative transesophageal echocardiography, neurologic protection during aortic surgery, resident teaching
Awards & Honors
Cardiothoracic Anesthesia Instructor of the Year in 2004 and 2005.
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 4/28/2015, Dr. Wallace has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.